Fujisawa T, Kaneko T, Kumagai T, Akamatsu T, Katsuyama T, Kiyosawa K, Tachikawa T, Kosaka O, Machikawa F
Second Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Japan.
J Clin Lab Anal. 2001;15(3):154-9. doi: 10.1002/jcla.1019.
There is increasing interest in noninvasive tests for the diagnosis of Helicobacter pylori (H. pylori) infection. One such test, a urine-based rapid test kit (RAPIRUN H. pylori Antibody, Otsuka Pharmaceutical Co., Ltd.) for detection of antibody to H. pylori, has been developed and is considered ideal. In addition to its noninvasiveness and safe handling-due to use of urine as a sample-the assay procedure used for the urinary rapid test is very simple. Only 10-20 minutes are required to complete an assay, and no instruments are needed. The aim of this study was to examine the clinical usefulness of this urine-based rapid test. A total of 189 patients, including 76 patients with gastroduodenal disease, were recruited. A pair of random single-void urine and serum samples was collected from each of the 189 patients, and antibody to H. pylori in the urine and serum samples was measured using the urine-based rapid test kit and three commercially available serum-based ELISA kits. For the patients with gastroduodenal disease, invasive diagnostic methods using endoscopic biopsy specimens such as culture, histology, and rapid urease test were also performed. The sensitivity, specificity, and accuracy of the urinary rapid test were evaluated on the basis of the three serum ELISA results or the invasive diagnostic results. In addition, various urinalyses were performed, and the effects of substances existing in urine on the urinary rapid test results were examined. Of the 189 patients, the urinary rapid test was positive for 110 (58.2%), negative for 78 (41.3%), and invalid for only one patient (0.5%). Based on the three serum-based ELISA results, the sensitivity, specificity, and accuracy of the urinary rapid test were 93.7, 88.9, and 92.2%, respectively. On the basis of the biopsy-based test results, the sensitivity of the urinary rapid test was 100% and its accuracy (95.2%) was equivalent or superior to that of each serum-based ELISA. In addition, no significant differences were observed between groups positive and negative on urinary rapid testing in any urinalysis parameter examined. The novel urinary rapid test kit evaluated in this study enables simple, rapid, and accurate diagnosis of H. pylori infection, and is an ideal test method for point-of-care testing.
对于幽门螺杆菌(H. pylori)感染的诊断,非侵入性检测方法越来越受到关注。其中一种检测方法,即用于检测幽门螺杆菌抗体的基于尿液的快速检测试剂盒(RAPIRUN H. pylori抗体,大冢制药株式会社)已经研发出来,并被认为是理想的检测方法。除了具有非侵入性以及由于使用尿液作为样本而便于安全操作外,尿液快速检测所采用的检测程序非常简单。完成一次检测仅需10 - 20分钟,且无需仪器。本研究的目的是检验这种基于尿液的快速检测的临床实用性。总共招募了189名患者,其中包括76名患有胃十二指肠疾病的患者。从这189名患者中每人采集一份随机单次晨尿样本和一份血清样本,并使用基于尿液的快速检测试剂盒以及三种市售的基于血清的酶联免疫吸附测定(ELISA)试剂盒来检测尿液和血清样本中的幽门螺杆菌抗体。对于患有胃十二指肠疾病的患者,还采用了使用内镜活检标本的侵入性诊断方法,如培养、组织学检查和快速尿素酶试验。基于三种血清ELISA结果或侵入性诊断结果评估尿液快速检测的敏感性、特异性和准确性。此外,进行了各种尿液分析,并研究了尿液中存在的物质对尿液快速检测结果的影响。在这189名患者中,尿液快速检测结果为阳性的有110例(58.2%),阴性的有78例(41.3%),仅有1例患者检测无效(0.5%)。基于三种基于血清的ELISA结果,尿液快速检测的敏感性、特异性和准确性分别为93.7%、88.9%和92.2%。基于活检检测结果,尿液快速检测的敏感性为100%,其准确性(95.2%)与每种基于血清的ELISA相当或更高。此外,在任何检测的尿液分析参数方面,尿液快速检测呈阳性和阴性的组之间未观察到显著差异。本研究中评估的新型尿液快速检测试剂盒能够实现对幽门螺杆菌感染的简单、快速且准确的诊断,是即时检测的理想检测方法。